{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:25:52Z","timestamp":1792027552873,"version":"4.4.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Sarcopenia, an age-related syndrome characterized by decreased muscle mass and performance, has been increasingly linked to high cardiovascular disease (CVD) risk. In this study, sarcopenia and probable sarcopenia were diagnosed according to the Asian Working Group for Sarcopenia (AWGS) 2019 criteria. However, specific biomarkers underlying this association, such as the triglyceride-glucose-waist-to-height ratio (TyG-WHtR), remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cohort of 2,521 adults \u226545 years with sarcopenia or probable sarcopenia (2011-2020) were stratified by TyG-WHtR tertiles: T1 (\u22644.30), T2 (4.30\u20135.01), and T3 (&amp;gt;5.01). To quantify the predictive utility of TyG-WHtR for CVD, methods such as Cox proportional hazards models, restricted cubic splines, and threshold regression analyses were utilized.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Over 7.3 years (median), incident CVD was documented in 727 individuals, including 258 patients who had a stroke and 560 patients who had heart diseases. Adjusted Cox models revealed that higher TyG-WHtR was independently associated with increased CVD risk: each one-unit increase corresponded to an 11% higher CVD risk (HR 1.11, 95% CI 1.01\u20131.22) and a 25% higher stroke risk (HR 1.25, 95% CI 1.06\u20131.47). Tertile analyses showed graded associations, with individuals in the highest tertile (T3) having a 51% higher risk of CVD, 90% higher risk of stroke, and 42% higher risk of heart diseases compared with T1. Threshold regression revealed a nonlinear relationship: when TyG-WHtR exceeded 3.76, CVD risk rose markedly (HR 1.22, <jats:italic>p<\/jats:italic> &amp;lt;.001), while below this threshold, lower TyG-WHtR levels were associated with reduced CVD risk (HR 0.80, <jats:italic>p<\/jats:italic> = .037).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In individuals with sarcopenia or probable sarcopenia, high TyG-WHtR is independently associated with higher CVD risk, demonstrating a distinct threshold effect. TyG-WHtR may be a valuable marker for predicting CVD risk in this population, thus enabling early cardiovascular risk stratification and personalized interventions for this group. However, these findings still require further validation through large-scale studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1686885","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:16:54Z","timestamp":1760329014000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between the triglyceride-glucose-waist-to-height ratio and cardiovascular disease in Chinese adults with sarcopenia or probable sarcopenia"],"prefix":"10.3389","volume":"16","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-024-00550-w","article-title":"Sarcopenia","volume":"10","author":"Sayer","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e041879","DOI":"10.1136\/bmjopen-2020-041879","article-title":"Prevalence of sarcopenia in older Chinese adults: a systematic review and meta-analysis","volume":"11","author":"Xin","year":"2021","journal-title":"BMJ Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)31138-9","article-title":"Sarcopenia","volume":"393","author":"Cruz-Jentoft","year":"2019","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001112","article-title":"Management of acute coronary syndrome in the older adult population: A scientific statement from the american heart association","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.064071","article-title":"Sarcopenia and cardiovascular diseases","volume":"147","author":"Damluji","year":"2023","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13160","article-title":"Recent sarcopenia definitions-prevalence, agreement and mortality associations among men: Findings from population-based cohorts","volume":"14","author":"Westbury","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000527804","article-title":"Probable sarcopenia, obesity, and risk of all-cause mortality: A pooled analysis of 4,612 participants","volume":"69","author":"S\u00e4\u00e4ksj\u00e4rvi","year":"2023","journal-title":"Gerontology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.eclinm.2021.101264","article-title":"Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study","volume":"44","author":"Gao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s12916-024-03841-x","article-title":"Changes in sarcopenia and incident cardiovascular disease in prospective cohorts","volume":"22","author":"Zeng","year":"2024","journal-title":"BMC Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2020.03.004","article-title":"The prevalence of sarcopenia and subtypes in cardiovascular diseases, and a new diagnostic approach","volume":"76","author":"Sasaki","year":"2020","journal-title":"J Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e13923","DOI":"10.1111\/acel.13923","article-title":"Causal associations of sarcopenia-related traits with cardiometabolic disease and Alzheimer\u2019s disease and the mediating role of insulin resistance: A Mendelian randomization study","volume":"22","author":"Ye","year":"2023","journal-title":"Aging Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","author":"Defronzo","year":"2009","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02115-9","article-title":"The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018","volume":"23","author":"Dang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12933-024-02336-6","article-title":"Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study","volume":"23","author":"Ren","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","article-title":"Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China health and retirement longitudinal study (CHARLS)","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"B18","article-title":"Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults","volume":"20","author":"Wen","year":"2011","journal-title":"Asia Pac J Clin Nutr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13541","article-title":"Bidirectional transitions of sarcopenia states in older adults: The longitudinal evidence from CHARLS","volume":"15","author":"Luo","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B20","doi-asserted-by":"publisher","first-page":"100259","DOI":"10.1016\/j.jnha.2024.100259","article-title":"Relationships between sarcopenia, depressive symptoms, and the risk of cardiovascular disease in Chinese population","volume":"28","author":"Xue","year":"2024","journal-title":"J Nutr Health Aging"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"B22","doi-asserted-by":"publisher","first-page":"102236","DOI":"10.1016\/j.eclinm.2023.102236","article-title":"Social isolation, loneliness, and incident type 2 diabetes mellitus: results from two large prospective cohorts in Europe and East Asia and Mendelian randomization","volume":"64","author":"Song","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","article-title":"Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Min","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02572-w","article-title":"Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank","volume":"24","author":"Qiao","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","article-title":"Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12933-025-02621-y","article-title":"The association of triglyceride-glucose and triglyceride-glucose related indices with the risk of heart disease in a national","volume":"24","author":"Tang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12902-024-01729-8","article-title":"The association between triglyceride-glucose index combined with obesity indicators and stroke risk: A longitudinal study based on CHARLS data","volume":"24","author":"Liang","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i3.101488","article-title":"Triglyceride-glucose related indices as predictors for major adverse cardiovascular events and overall mortality in type-2 diabetes mellitus patients","volume":"16","author":"Liu","year":"2025","journal-title":"World J Diabetes"},{"key":"B30","doi-asserted-by":"publisher","first-page":"102267","DOI":"10.1016\/j.arr.2024.102267","article-title":"Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia","volume":"96","author":"Livshits","year":"2024","journal-title":"Ageing Res Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"156148","DOI":"10.1016\/j.metabol.2025.156148","article-title":"Exploring receptors for pro-resolving and non-pro-resolving mediators as therapeutic targets for sarcopenia","volume":"165","author":"Wang","year":"2025","journal-title":"Metabolism"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae073","article-title":"Biological basis and treatment of frailty and sarcopenia","volume":"120","author":"Sato","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jjcc.2021.10.013","article-title":"Sarcopenia as a comorbidity of cardiovascular disease","volume":"79","author":"Sasaki","year":"2022","journal-title":"J Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"102587","DOI":"10.1016\/j.arr.2024.102587","article-title":"Sarcopenia and the biological determinants of aging: A narrative review from a geroscience perspective","volume":"103","author":"Nunes-Pinto","year":"2025","journal-title":"Ageing Res Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"100980","DOI":"10.1016\/j.arr.2019.100980","article-title":"Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis","volume":"56","author":"Livshits","year":"2019","journal-title":"Ageing Res Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"155639","DOI":"10.1016\/j.metabol.2023.155639","article-title":"Sarcopenic obesity: emerging mechanisms and therapeutic potential","volume":"146","author":"Axelrod","year":"2023","journal-title":"Metabolism"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/jci158471","article-title":"The foxOs are in the apoM house","volume":"132","author":"Linton","year":"2022","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/s2666-7568(22)00247-1","article-title":"Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study","volume":"4","author":"Lopez-Jaramillo","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0379","article-title":"Change in cardiovascular health and incident type 2 diabetes and impaired fasting glucose: the whitehall II study","volume":"42","author":"Climie","year":"2019","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e664","DOI":"10.1002\/mco2.664","article-title":"The cellular and molecular targets of natural products against metabolic disorders: a translational approach to reach the bedside","volume":"5","author":"Shen","year":"2024","journal-title":"MedComm (2020)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0256-0","article-title":"Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions","volume":"15","author":"Ferguson","year":"2019","journal-title":"Nat Rev Rheumatol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1686885\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:16:55Z","timestamp":1760329015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1686885\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":42,"alternative-id":["10.3389\/fendo.2025.1686885"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1686885","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"article-number":"1686885"}}